Clinical Trial Update: Suzetrigine in Total Hip Arthroplasty [Phase 3]

View source ↗

Summary

Suzetrigine is being evaluated in a Phase 3 trial for pain management in patients undergoing total hip arthroplasty and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Hip Arthroplasty

Drugs mentioned

• Suzetrigine (Suzetrigine)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Total Hip Arthroplasty (THA), Total Hip Arthroplasty \(THA\) | Phase 3 | Status: RECRUITING